

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 25mg | 360 pills | C$1.01 | C$454.08 C$363.26 Best Price | |
| 25mg | 180 pills | C$1.09 | C$244.30 C$195.44 | |
| 25mg | 120 pills | C$1.26 | C$190.01 C$152.01 | |
| 25mg | 90 pills | C$1.44 | C$162.86 C$130.29 | |
| 25mg | 60 pills | C$1.64 | C$123.37 C$98.70 | |
| 25mg | 30 pills | C$2.70 | C$101.16 C$80.93 | |
| 50mg | 360 pills | C$1.30 | C$587.34 C$469.88 | |
| 50mg | 180 pills | C$1.42 | C$320.81 C$256.65 | |
| 50mg | 120 pills | C$1.56 | C$234.43 C$187.54 | |
| 50mg | 90 pills | C$1.78 | C$199.88 C$159.90 | |
| 50mg | 60 pills | C$1.86 | C$138.18 C$110.54 | |
| 50mg | 30 pills | C$2.17 | C$81.42 C$65.13 | |
| 100mg | 360 pills | C$1.78 | C$799.59 C$639.67 Popular | |
| 100mg | 180 pills | C$1.93 | C$434.33 C$347.47 | |
| 100mg | 120 pills | C$2.09 | C$313.40 C$250.72 | |
| 100mg | 90 pills | C$2.33 | C$261.58 C$209.26 | |
| 100mg | 60 pills | C$2.45 | C$182.60 C$146.08 | |
| 100mg | 30 pills | C$2.90 | C$108.56 C$86.85 |
Disclaimer: This information is intended to support, not replace, professional medical advice. Speak with a pharmacist or clinician for guidance tailored to individual health needs.
Sleep disturbance is a common feature of mood disorders and may worsen daytime functioning. Addressing sleep problems can support overall treatment of mood symptoms. Desyrel is the brand name for trazodone, a medicine with a distinctive pharmacological profile that includes antidepressant activity and sedative effects.
Trazodone belongs to a class of antidepressants known as serotonin antagonists and reuptake inhibitors (SARI). This means it influences serotonin signaling in the brain, which is involved in mood regulation and sleep. The sedative effect is often helpful when insomnia accompanies depressive symptoms, but it can also contribute to daytime drowsiness in some people.
In Canada, Desyrel (trazodone) is typically dispensed with a clinician’s prescription, depending on local rules. The medication may be prescribed for major depressive disorder and, in some cases, used off-label for sleep difficulties linked to mood symptoms. The decision to use Desyrel should consider potential benefits for mood alongside the risk of side effects and interactions with other medicines.
Safety monitoring is commonly recommended during treatment. The clinician may review liver function tests, kidney function, and the patient’s overall response to therapy. It is important to communicate any new symptoms promptly, and to discuss planned changes in other medicines or supplements with a healthcare professional.
Contraindications are conditions or factors that make a medicine unsafe to use. Identifying contraindications helps minimize the risk of serious harm.
Desyrel should not be used in the following situations without close medical supervision or evaluation by a clinician:
In other situations, a clinician may determine that benefits outweigh risks or may propose an alternative therapy. If any of the above apply, discuss plans with a healthcare professional before starting Desyrel.
Warnings identify situations that require more careful monitoring or may signal potential safety concerns. The following points should be reviewed by the prescribing clinician and patient prior to and during therapy.
Monitoring may include assessment for mood changes, suicidality (particularly in younger patients or those with a history of mood disorders), and any new or worsening symptoms. Sudden mood changes or unusual behavior should be reported promptly to a clinician or pharmacist, especially at treatment initiation or dose changes.
Desyrel has the potential to affect heart rhythm in rare cases. Electrolyte disturbances, dehydration, or coexisting heart conditions can increase risk. Individuals with known heart rhythm problems or those taking other medicines that affect heart rhythm should be monitored closely.
Serotonin-related interactions with other serotonergic medicines (for example, antidepressants, migraine medicines, or certain supplements) may raise the risk of a rare but serious condition called serotonin syndrome. Symptoms may include confusion, rapid heart rate, high blood pressure, dilated pupils, loss of coordination, or high fever. Immediate medical attention is required if these signs appear.
Orthostatic hypotension (sudden drop in blood pressure upon standing) can occur, increasing the risk of dizziness or fainting. Caution is advised when starting treatment or increasing the dose, particularly in older adults or those taking other medicines that lower blood pressure.
Side effects may vary in frequency and intensity. Most adverse effects are transient and may lessen with continued therapy or dose adjustments. Reporting persistent or troublesome symptoms to a clinician or pharmacist is advised.
Common side effects are typically dose-related and often occur early in treatment. Less common, more serious effects require medical evaluation. A healthcare professional should be consulted if new symptoms arise or if any symptom worsens significantly.
In Canada, reporting concerns about adverse effects to health authorities or the manufacturer’s safety program is encouraged, and information can be discussed with a pharmacist for guidance on management or alternatives.
Drowsiness, sedation, dizziness, and sometimes impaired concentration may occur. These effects are more noticeable when starting treatment or after a dose change and may affect activities such as driving or operating machinery.
Lightheadedness on standing, fainting, or palpitations have been reported rarely. In individuals with known heart rhythm abnormalities, closer monitoring may be recommended. Any new chest discomfort or irregular heartbeat should be evaluated promptly by a clinician.
Nausea, dry mouth, upset stomach, constipation, or diarrhea can occur. These symptoms are usually mild and transient but should be discussed if persistent or troublesome.
Rash, itching, or rarely more serious allergic reactions may occur. Severe skin reactions are uncommon but require immediate medical evaluation.
Weight changes, blurred vision, and headache have been reported in some patients. Sleep disturbances or vivid dreams may occur in rare cases. If any effect becomes persistent or bothersome, seek medical advice.
Drug interactions can alter how Desyrel works or increase the risk of adverse effects. A clinician or pharmacist should review all medicines and supplements prior to starting trazodone.
Interactions are grouped by type to support safe decision-making. When in doubt, always consult a health professional before adding a new medicine, supplement, or changing doses.
In Canada, pharmacists can access patient information and provide counseling to help minimize interaction risks. A shared decision with a clinician will help determine suitable alternatives if necessary.
Where uncertainties exist, the reader should check the official patient information leaflet or consult a pharmacist or clinician for individualized guidance. Do not start or stop any medicine without professional advice.
Special populations require adjusted risk assessment and careful monitoring. The safety profile and potential effects on fetus or infant must be weighed against the expected benefits for the mother or caregiver.
Pregnancy and breastfeeding: Safety data for trazodone in pregnancy and breastfeeding are limited. A clinician will consider potential benefits and risks before prescribing during pregnancy or lactation. If pregnancy occurs while taking Desyrel, contact a clinician promptly to discuss options.
Elderly patients: Age-related changes in drug metabolism and increased sensitivity to sedative effects may affect dosing and safety. Caution is advised, with closer monitoring for dizziness, falls, and interactions with other medicines commonly used in older adults.
Children and adolescents: The safety and effectiveness of trazodone in younger populations require careful clinical justification. In many settings, prescribing should follow a clinician’s specific guidance, with attention to mental health needs and sleep patterns.
Usage instructions are designed to support safe and effective treatment while minimizing risks. The following guidance is provided for general reference and does not replace professional instruction from a clinician or pharmacist.
Desyrel is usually taken by mouth, with or without food. Dosing schedules may be chosen to suit sleep goals and daily routines, particularly when sedation is desired at night. Quick changes in dose or frequency should be avoided unless advised by a clinician.
Do not stop trazodone abruptly. A clinician often recommends a gradual taper to reduce the risk of withdrawal symptoms or mood instability. Any planned discontinuation should be discussed with a healthcare professional.
If a dose is missed, consult a clinician or pharmacist for specific instructions. Generally, missed doses should not be doubled to make up for the missed dose, as this may increase the risk of adverse effects.
In the event of an suspected overdose, seek urgent medical help. Signs of overdose may include extreme drowsiness, confusion, fainting, or difficulty breathing. Do not rely on self-treatment; professional evaluation is essential.
During treatment, it is important to keep Desyrel out of reach of children and to follow local disposal guidance for unused medicines. A healthcare professional can provide instructions for safe disposal if needed.
Alcohol can increase sedation and dizziness when combined with trazodone. The combination may impair coordination or reaction time and is often discouraged. If alcohol is consumed, it should be discussed with a clinician, and intake should be limited or avoided depending on individual risk factors.
Drowsiness or dizziness may occur, especially early in treatment or after dose changes. Activities requiring alertness should be approached with caution until tolerance is established. If significant impairment is present, avoid driving or operating dangerous machinery until cleared by a clinician.
Persistent severe sleepiness should be reported to a clinician promptly. A dose adjustment or a change in timing (usually at night) may help. Do not alter the dose without professional advice.
Caffeine itself can affect sleep quality and daytime alertness. While no universal rule applies to all individuals, excessive stimulant intake may complicate sleep-related symptoms. Discuss caffeine habits with a clinician if concerns arise.
Routine blood testing is not universally required for all patients taking trazodone. A clinician may order tests if liver or kidney function is a concern, or if other medications warrant monitoring. Follow the clinician’s instructions for any planned testing.
Treatment response may take several weeks. If there is no improvement in mood or sleep after an appropriate trial, a clinician may reassess the regimen, consider dose adjustments, or explore alternative therapies. Do not discontinue on your own without guidance.
Combination therapy with trazodone and other antidepressants requires careful supervision due to the potential for interactions or serotonin-related effects. A clinician will determine whether a combined approach is appropriate and safe.
Serotonin syndrome is rare but serious and can occur when trazodone is used with other serotonergic medicines. Early signs include agitation, fever, confusion, rapid heart rate, and abnormal movements. Immediate medical evaluation is required if such symptoms occur.
Safety in pregnancy has not been fully established. A clinician will balance potential benefits for the mother against potential risks to the fetus. If pregnancy occurs during treatment, seek medical advice promptly.
Improvements in mood and sleep may be gradual, often over several weeks. If no improvement is noted after an adequate trial, a clinician may reassess the treatment plan. Do not adjust medications without professional guidance.
Worsening mood, suicidal thoughts, severe dizziness, fainting, chest pain, or severe allergic reactions require immediate medical attention. Discuss any persistent adverse effects with a clinician for tailored guidance.
Reliable information about Desyrel and trazodone can be found in official patient information leaflets, Health Canada product monographs, and clinical guidance documents. Pharmacists are available to answer questions about safe use, potential interactions, and adjustments based on individual health needs.
When seeking guidance, reference materials should be current and consistent with local regulatory rules. For country-specific information in Canada, consult the official leaflet supplied with the medication and discuss concerns with a licensed pharmacist or clinician.
Any changes to therapy should be discussed with a clinician before implementation. If a new symptom or interaction is suspected, contact a healthcare professional promptly to ensure safety and appropriate care. It is advised to keep a current list of all medicines, including OTC products and supplements, to support safe prescribing and monitoring.
14–21 days. Free from C$282.05 .
5–9 days. C$42.31
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
